Results 271 to 280 of about 849,024 (375)
Typing of hepatitis C virus genomes by restriction fragment length polymorphism
T. Nakao+4 more
openalex +1 more source
Abstract Aims The extent of irreversible cardiomyocyte necrosis after acute myocardial infarction (AMI) is a major determinant of residual left ventricular (LV) function and clinical outcome. Cell therapy based on CD34+ cells has emerged as an option to help repair the myocardium and to improve outcomes.
Jerome Roncalli+17 more
wiley +1 more source
Hepatitis C virus-free endoscope procedures project: An in-hospital elimination approach. [PDF]
Hsieh BL+10 more
europepmc +1 more source
Discovering new hub genes of dilated cardiomyopathy
Abstract Aims Dilated cardiomyopathy (DCM) has a poor prognosis and exhibits a complex and diverse aetiology and genetic profile. The genes responsible for the pathogenesis of DCM have not been fully identified. The present study aimed to explore new hub genes of DCM by mining the human DCM databases and further by experimental validation.
Jun‐Yan Zhu+9 more
wiley +1 more source
Serological responses to different genotypes of hepatitis C virus in France [PDF]
Cristina Alonso+9 more
openalex +1 more source
Acute myocarditis according to age: Presentation, management and early outcomes
MIS, multisystem inflammatory syndrome; MRE, myocarditis‐related events (within 30 days included all‐cause death, cardiogenic shock, cardiac arrest, ventricular arrhythmias or complete AV block). Abstract Aims Acute myocarditis (AM) is a rare but severe disease affecting patients of all ages. Large multicentric studies comparing children and adults are
Clément Karsenty+25 more
wiley +1 more source
Interferon treatment for chronic hepatitis C virus infection in uremic patients
Paul-Albert Koenig+8 more
openalex +1 more source
Naturally occurring point mutation in the C terminus of the polymerase gene prevents duck hepatitis B virus RNA packaging [PDF]
Y Chen+2 more
openalex +1 more source
A cyclobutane ring constitutes an interesting scaffold for the development of new materials and drugs. In this work we describe the [2+2] cycloaddition of chalconoid precursors bearing fluorinated and heterocyclic moieties to produce cyclobutane derivatives in solution.
Concepcion Perez-Melero+3 more
wiley +1 more source